AIVIS

The startup develops AI services for analyzing hematoxylin and eosin (HE) stained tissue slides, utilizing advanced image analysis techniques to extract critical medical information not visible to the human eye. This technology eliminates the need for immunohistochemical (IHC) staining, enabling pathologists to more accurately predict breast cancer treatment and prognosis.

Traction 4/10

HQ unknown

Founded 202130200+ followers

Artificial Intelligence
Data & Analytics
Digital Health
Healthcare Technology
Software Only

Updated 7 months ago

Funding

Funding rounds are not available yet.

Founders

1 founder

Daehong Lee

CEO

Product

Features

The startup develops AI services for analyzing hematoxylin and eosin (HE) stained tissue slides, utilizing advanced image analysis techniques to extract critical medical information not visible to the human eye. This technology eliminates the need for immunohistochemical (IHC) staining, enabling pathologists to more accurately predict breast cancer treatment and prognosis.